ECP For Cardiac Issues

Counterpulsation for Heart Failure 

 EECP appears safe when applied as adjunct therapy for heart failure. 

Efficacy results suggest that EECP can improve exercise tolerance capacity, quality of life and functional status, both in the short term and also for a period of 6 months after completion of the EECP therapy Results of the study warrant the initiation of a randomized controlled study to ascertain the effectiveness of EECP therapy in the management of patients with chronic stable heart failure. 


Counterpulsation following Heart Attack

Counterpulsation can reduce angina and extend the time to ischemia and increase exercise tolerance in patients with symptomatic Coronary Artery Disease.

Those patients who showed no initial response reported significantly unstable angina in the two-year period. Counterpulsation offered a safe treatment option for patients who have LV dysfunction and angina pectoris.